The treatment of transarterial chemoembolization/hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor is effective against hepatocellular carcinoma with portal vein tumor thrombus: A systematic review

The treatment of transarterial chemoembolization/hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor is effective against hepatocellular carcinoma with portal vein tumor thrombus: A systematic review

BackgroundLenvatinib combined with programmed cell death protein-1 inhibitor has achieved good survival results in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Transarterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC) has attracted attentio...

Full description

Bibliographic Details
Main Authors: Gao Yuanren, Linan Yin, Ruibao Liu, Yali Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
lenvatinib
PD-1 inhibitor
TACE
HAIC
liver cancer
portal vein tumor thrombus
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1054072/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1054072/full

Similar Items